Maravai LifeSciences Holdings Inc. Class A Common Stock vs First Trust Cloud Computing ETF — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while First Trust Cloud Computing ETF trades at $161.99 (market cap $3.56B). The key difference: First Trust Cloud Computing ETF is far larger — about 3.6× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and First Trust Cloud Computing ETF is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and First Trust Cloud Computing ETF for 84 Days on average.
| MRVI | SKYY | |
|---|---|---|
Market Cap | $977.37M | $3.56B |
Volume | 2,742,564 | 272,580 |
Sector | Health | — |
52-Week High | $9.00 | $174.89 |
52-Week Low | $2.83 | $104.16 |
Typical Hold Time | 0 Days | 84 Days |
Enterprise Value | $1.08B | — |
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
First Trust Cloud Computing ETF (SKYY) trades at $171.52, down 0.57% on the day but remains near its 52-week high of $169.41. Technical indicators show a bullish trend with strong moving average support, though RSI suggests mild overbought conditions. The ETF provides diversified exposure to cloud computing companies benefiting from AI adoption and digital transformation trends, with recent articles highlighting the sector's growth potential.
The cloud computing sector shows strong secular growth drivers including AI infrastructure spending and cloud migration. While technical momentum remains positive, investors should monitor valuation levels given the ETF's proximity to recent highs. Sector concentration and technology volatility present key risks, though institutional interest in cloud infrastructure remains robust.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →